Alethea Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Alethea Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	+18,892	New	+$1.08M	0.45%	12
2023 Q4	–	Sell	-7,315	Closed	-$425K	–	37
2023 Q3	$425K	Buy	+7,315	New	+$448K	0.52%	17
2023 Q2	–	Sell	-8,965	Closed	-$621K	–	56
2023 Q1	$621K	Buy	+8,965	New	+$632K	0.66%	17
2020 Q4	–	Sell	-10,487	Closed	-$632K	–	76
2020 Q3	$632K	Sell	10,487 -15,306	-59%	-$921K	0.43%	31
2020 Q2	$1.52M	Buy	25,793 +4,571	+22%	+$273K	0.89%	8
2020 Q1	$1.18M	Buy	+21,222	New	+$1.3M	0.77%	11
2019 Q1	–	Sell	-26,873	Closed	-$1.4M	–	78
2018 Q4	$1.4M	Buy	+26,873	New	+$1.44M	2.03%	12
2018 Q2	–	Sell	-7,752	Closed	-$490K	–	68
2018 Q1	$490K	Buy	+7,752	New	+$499K	0.66%	40
2017 Q3	–	Sell	-27,038	Closed	-$1.51M	–	79
2017 Q2	$1.51M	Buy	+27,038	New	+$1.47M	1.71%	20
2017 Q1	–	Sell	-27,392	Closed	-$1.6M	–	77
2016 Q4	$1.6M	Buy	27,392 +11,109	+68%	+$607K	2.02%	17
2016 Q3	$878K	Buy	+16,283	New	+$1.05M	1.22%	28
2015 Q4	–	Sell	-8,190	Closed	-$485K	–	70
2015 Q3	$485K	Sell	8,190 -2,025	-20%	-$128K	0.74%	33
2015 Q2	$680K	Buy	+10,215	New	+$673K	1.04%	20

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Alethea Capital Management's BMY Position: Q2 2026 in Review

Alethea Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 18,892 shares worth $1.09M. The stake represents 0.45% of the portfolio and ranks #12 among its holdings. This is a return to the name: Alethea Capital Management previously reported a position in BMY as recently as Q3 2023.

Alethea Capital Management first reported a position in BMY in Q2 2015 and has held it in 13 quarters since. The position peaked at $1.6M in Q4 2016. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Alethea Capital Management held 18,892 shares of Bristol-Myers Squibb worth $1.09M as of Q2 2026.
Bristol-Myers Squibb was a new Alethea Capital Management position in Q2 2026.
Bristol-Myers Squibb made up 0.45% of Alethea Capital Management's portfolio in Q2 2026, its #12 holding.
Alethea Capital Management first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 13 quarters since.
Alethea Capital Management's Bristol-Myers Squibb position peaked at $1.6M in Q4 2016.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Alethea Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.